Lilly files anti-CGRP drug for migraine

12th December 2017 Uncategorised 0

US regulators have accepted for review Eli Lilly’s investigational non-opioid pain drug galcanezumab for the prevention of migraine.

More: Lilly files anti-CGRP drug for migraine
Source: News